Docteur Etienne HUVELLE Urgentiste SMA



Similar documents
Echocardiography Guided Cardiac Resynchronization Therapy in Patients with Symptomatic Heart Failure and Narrow QRS Complex

Updated Cardiac Resynchronization Therapy Guidelines

ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)

How should we treat atrial fibrillation in heart failure

Basics of Pacing. Ruth Hickling, RN-BSN Tasha Conley, RN-BSN

Introduction to Electrophysiology. Wm. W. Barrington, MD, FACC University of Pittsburgh Medical Center

Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI

CCAD Training Manual. Cardiac Rhythm Management (CRM)

Chronic Vagus Nerve Stimulation: A New Treatment Modality for Congestive Heart Failure

DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

STANDARDS FOR IMPLANTATION AND FOLLOW-UP OF CARDIAC RHYTHM MANAGEMENT DEVICES IN ADULTS January 2013

Section Four: Pulmonary Artery Waveform Interpretation

COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra

Implantable Cardioverter Defibrillator Treatment: Benefits and Pitfalls in the Currently Indicated Population. Carel Jan Willem Borleffs

Pacemaker Counter and Histogram Operation and Interpretation. Percentage of total count. Figure 2. Detailed ALTRUA Paced and Sensed Event Counters

Diagnosis Code Crosswalk : ICD-9-CM to ICD-10-CM Cardiac Rhythm and Heart Failure Diagnoses

Heart Rhythm UK. Standards for Implantation and Follow-up of Cardiac Rhythm Management Devices HRUK, February 2011

How do you decide on rate versus rhythm control?

LEFT VENTRICULAR LEAD PLACEMENT IN THE LATEST ACTIVATED REGION GUIDED BY CORONARY VENOUS ELECTROANATOMIC MAPPING

Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease

Treatment of cardiogenic shock

Technology Assessment

Rome, Italy December 4-7, 2012 Rome Cavalieri TIMETABLE

Reimbursement Information For Electrophysiology and Arrhythmia Service Procedures 1

2013 Medicare Physician Coding and Reimbursement Changes

Management of Symptomatic Atrial Fibrillation

CURRICULUM VITAE Prof. ANTONIO CURNIS

A randomized, controlled trial comparing the efficacy of carvedilol vs. metoprolol in the treatment of atrial fibrillation

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Device Therapy: the future is now.

Le complicanze nei portatori di ICD e CRT

Medtronic Cardiac Rhythm and Heart Failure ICD-10 Coding for Physicians

UCSF Anesthesia Resident Pearls: Cardiac Implantable Electronic Devices: Pacemakers and ICDs Table of Contents

Disclosures. Anesthesia and Lead Extractions. Lead Extractions: Objectives. Lead Removal Techniques. None

Innovation Platform: Sudden Cardiac Death

2014: nowadays the one shot technologies and the injectable monitor allow a wide and complete AF patient management. Why shouldn t we use them?

GuidePoint. Physician Reimbursement Primer for Cardiac Rhythm Management. With Clinical Case Examples. GuidePoint is simplifying reimbursement.

How To Improve Health Care For Remote Workers

Cardiogenic shock: invasive and non-invasive monitoring John T. Parissis Attikon University Hospital Athens, Greece

Pacers use a 5-letter code: first 3 letters most important

Recurrent AF: Choosing the Right Medication.

NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3

Atrial Fibrillation The Basics

Michael Hartman, CRNA, DNP, MSN, BSN, BA

What Are Arrhythmias?

GUIDELINE 11.9 MANAGING ACUTE DYSRHYTHMIAS. (To be read in conjunction with Guideline 11.7 Post-Resuscitation Therapy in Adult Advanced Life Support)

How to control atrial fibrillation in 2013 The ideal patient for a rate control strategy

Tachyarrhythmias (fast heart rhythms)

ARIZONA ARRHYTHMIA CONSULTANTS

HTEC 91. Topic for Today: Atrial Rhythms. NSR with PAC. Nonconducted PAC. Nonconducted PAC. Premature Atrial Contractions (PACs)

while the incidence of atrial fibrillation

INTRODUCTORY GUIDE TO IDENTIFYING ECG IRREGULARITIES

The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It?

CARDIAC ELECTROPHYSIOLOGY, ARRHYTHMIAS AND PACING. Medical Knowledge. Goals and Objectives PF EF MF LF Aspirational

DISCLOSURES. I am a consultant for Biosense Webster St Jude Medical

«Δυσλειτουργία βηματοδότη. Πως μπορούμε να την εκτιμήσουμε στο ιατρείο.» Koσσυβάκης Χάρης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ. ΓΕΝΝΗΜΑΤΑΣ

Introduction. Planned surgical procedures

1p36 and the Heart. John Lynn Jefferies, MD, MPH, FACC, FAHA

Implantable pacemakers and implantable cardioverter

Wide-Complex Tachycardias in the ED: Myths and Pitfalls

50 years of CRM Device Therapy Past, Present and Future. Richard Sutton Professor of Cardiology Imperial College, London, UK

Inpatient Heart Failure Management: Risks & Benefits

MULTIPLE CHOICE. Choose the one alternative that best completes the statement or answers the question.

ACLS Defibrillation Protocols With the ZOLL Rectilinear Biphasic Waveform AHA/ERC Guidelines 2005

DH Cardiac Rehabilitation Commissioning Pack: highlights and process. Prof Patrick Doherty BACR conference Liverpool 2010

Worldwide Experience with S-ICD: Early results from the EFFORTLESS Registry

The National Service Framework for Cardiac Disease: Strategic Aims and Implementation A Cardiac Work Programme for Wales

Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Management of Patients With. Learn and Live SM. ACC/AHA/ESC Pocket Guideline

Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology

Addendum to the Guideline on antiarrhythmics on atrial fibrillation and atrial flutter

UPMC HEALTH PLAN MANAGEMENT OF HEART FAILURE WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION: CLINICAL PRACTICE GUIDELINE

Diagnostic and Therapeutic Procedures

Karen Bain James Cook University Hospital Middlesbrough

Premature Ventricular Contractions. Ralph Augostini, MD FACC FHRS

Transcription:

Docteur Etienne HUVELLE Urgentiste SMA Diplômes Diplôme de Docteur en médecine, chirurgie et accouchements Ulg 1986. Diplôme d'ingénieur civil électricien option Ingéniérie Bimédicale Traitement de signal, Ulg, 1992. Diplômes complémentaires Certificat délectrocardiographie, Ulg, 1986 Certificat Advanced Life Support (ALS) European Resuscitation Concil (ERC), ULB, 2007. Certificat Ateliers de réanimation adulte en médecine d'urgence (ARAMU), ULB, 2007 Certificat BMA (Brevet médecine aiguë), ULB, 2077. Certificat d'enseignement du PREP (Programme rapide d'échographie du polytraumatisé), CHRN, Namur, 2007 ARAMU Sutures 2008 FORMAC 1, 2010 Publications HUVELLE E., FAY R., ALLA F., SOLAL A-C., MEBAZAA A., ZANNAD F. Left bundle branch block and mortality in patients with acute heart failure syndrome : a substudy of the EFICA cohort. Eur J Heart Fail. 2010 ; 12 (2) : 156-63. ZANNAD F., HUVELLE E., DICKSTEIN K., VAN VELDHUISEN D-J, STELLBRINK C., KOBER L., CAZEAU S., RITTER P., MAGGIONI A-P., FERRARI R., LECHAT P. Left bundle branch block as a risk factor for progression to heart failure. Eur J Heart Fail. 2007 ; 9 (1) : 7-14. AURICCHIO A., STELLBRINK C., BUTTER C., SACK S., VOGT J., MISIER A-R., BOCKER D., BLOCK M., KIRKELS J-H., KRAMER A., HUVELLE E. Pacing therapies in congestive heart failure II study group ; guidant heart failure research group. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacin in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll cardiol. 2003 ; 42 (12) : 2109-16. FENELON G., STAMBLER B-S., HUVELLE E., BRUGADA P., STEVENSON W-G. European VENTAK MINI investigator group. Left ventricular dysfunction in associated with prolonged average ventricular fibrillation cycle length in patients with implantale cardioverter defibrilaltors. J Interv Card Electrophysiol. 2002 ; 7 (3) : 249-54.

BREITHARDT O-A., STELLBRINK C., KRAMER A-P., SINHA A-M., FRANCKE A., SALO R., SCHIFFGENS B., HUVELLE E., AURICCHIO A. PATH-CHF study group. Pacing therapies for congestive heart failure. Echocardiographic quantification fo left ventricular asynchrony predicts an acute hemodynamic benefit of cardiac resynchronization therapy. J Am Coll Cardio. 2002 ; 40 (3( : 536-45. BUTTER C., AURICCHIO A., STELLBRINK C., FLECK E., DING J., YU Y., HUVELLE E., SPINELLI J. Pacing therapy for chronic heart failure II study group. Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients. Circulation 2001 ; 104 (25) : 3026-9. BUTTER C., AURICCHIO A., STELLBRINK C., SCHLEGL M., FLECK E., HORSCH W., HUVELLE E., DING J., KRAMER A. Should stimulation site be tailored in the individual heart failure patient? Am J Cardiol. 2000 ; 86 (9 supl 1) : K 144-K151. BREITHARDT O-A., STELLBRINK C., FRANCKE A., AURICCHIO A., HUVELLE E., SACK S., BAKKER P., HANRATH P. Echocardiographic evidence of hemodynamic and clinical improvement in patients paced for heart failure. Am J Cardiol. 2000 ; 86 (9 supll 1) : K133-K137. FENELON G., HUVELLE E., BRUGADA P. Initial clinical experience with a new small siezd third-generation implantable cardioverter defibrillator : results of a multicenter study. PACE 1997 ; 20 (12 Pt I) : 2967-2974. KLEIN H., HUVELLE E., NISAM S. Initial clinical experience with a nex down-sized implantable cardioverter defibrillator. Am J Cardiol 1996 ; 78 (supll 5A) : 9-14. Abstracts HUVELLE E., FAY R., ALLA F., SOLAL A-C., MEBAZAA A., ZANNAD F. Left bundle branch block and mortality in patients with acuter heart failure syndrome : a substudy of the EFICA cohort. HFA of the ESC (poster presentation. BUTTER C., STELLBRINK C., SCHLEGL M., SINHA A-M., CUESTA F., HUVELLE E., VILLALTA D-L., REISTER C. Hemodynamics. NASPE 2004 (poster prestentation). AURICCHIO A., GELLER C., KLOSS M., KLEIN H-U., CAZARES S., YU Y., DOELGER A., HUVELLE E. Effect of right ventricular pacing site on hemodynamic function during bi-ventricular pacing for heart failure patients with atrial fibrillation after atrioventricular node ablation. NASPE 2004 (oral presentation).

BUTTER C., STELLBRINK C., SACK S., VOGT J., RAMDAT-MISIER A., BOCKER D., BLOCK M., KIRKELS H., HUVELLE E., KRAMER A., POCHET T. Cardiac resynchronization therapy stratified by QRS duration : PATH-CHF-II results at one year. NASPE 2003 (oral presentation). AURICCHIO A., STELLBRINK C., BUTTER C., SACK S., VOGT J., RAMDAT-MISIER A., BOCKER D., BLOCK M., KIRKELS H., HUVELLE E., KRAMER A., POCHET T. Clinical efficacy of cardia resynchronization therapy in heart failure patients stratified by a severity of ventricular conduction delay : results of the PATH-CHF-II trial. NASPE 2002 Late breaking trial session (oral presentation). STELLBRINK C., AURICCHIO A., BUTTER C., KIRKELS H., KLOSS M., VOGT J., KRAMER A., SPINELLI J., HUVELLE E., DING J., CUESTA F. Acute hemodynamic improvement predicts chronic bnefit in heart failure patients treated with cardiac resynchronization. NASPE 2002 (oral presentation) DI PEDE F., GASPARINI G., RAVIELE A., PASTORE J., YU Y., CUESTA F., HUVELLE E. Effect of atrial stimulation site on the contractile function of heart failure patients with DDD biventricular pacing. NASPE 2002 (poster prestentation) BUTTER C., AURICCHIO A., STELLBRINK C., DING J., DOELGER A., HUVELLE E., SPINELLI J., LONGER L-V. RV delay may not yield better BiVRT outcomme in HF patients. Abstract#649. Eurospace July 2001, 2 (Supll B) : B11; SACK S., AURICCHIO A., STELLBRINK C., BOCKER D., VOGT J., BAKKER P., CUESTA P., HOERSCH W. HUVELLE E., SPINELLI J. Long-term functional capacity improvement in the PATH-CHF study. Abstract 586, Eurospace July 2001 ; 2 (Supll B) : B48. BREITHARDT O-A., KRAMER A., SALO R., SINHA A-M., HUVELLE E., AURICCHIO A., HANRATH P., SPINELLI J., STELLBRINK C. Predictive value of echocardiographic left ventricular contraction patterns in cardiac resynchronization therapy. Abstract 792, PACE April 2001 ; 24 (4, PartII) : 736 (NASPE 2001, poster presentation) BUTTER C., AURICCHIO A., STELLBRINK C., DING J., DOELGER A., HUVELLE E., SPINELLI J. Biventricular resynchronization therapy for heart failure patients : does longer RV-LV conduction delay always yield better hemodynamic responses? Abstract 61, PACE April 2001 ; 24 (4, Part II) : 629 (NASPE 2001 poster presentation). YU Y., AURICCHIO A., DING J., KRAMER A., HUVELLE E., POTTY P., SPINELLI J. Resynchronization between left and right ventricles responsible for improving hemodynamic function of heart failure patients with LBBB? Abstract 148, PACE April 2000 ; 23 (4, Part II) : 589. SACK S., AURICCHIO A., KADHISERAN V., SALO R., HUVELLE E., MICHEL U., SPINELLI J. Long term improvement with ventricular resynchronization therapy in heart failure patients : does etiology of heart failure matter? Abstract 10, PACE April 2000; 23 (4, Part II): 555.

YU Y., AURICCHIO A., DING J., KRAMER A., HOERSCH W., HUVELLE E., SPINELLI J. Identification of patiens suitable for ventricular resynchronization therapy based on normalized LV-RV pressure loop area. Abstract 9, PACE April 2000 ; 23 (4, Part II) : 555. FENELON G., HUVELLE E., BRUGADA P., STEVENSON W-G., STAMBLER B-S. Ventricular refractoriness is prolongated in human heart failure : analysis of the ventricular fibrillation intervals form implantable cardioverter defibrillators. Abstract 1870, Ciruclation (Supp) November 1997 ; 96 (8) (oral presentation) FENELON G., HUVELLE E., BRUGADA P. Initial clinical experience with a new small sized third-generation implantable cardioverter defibrillators : results of a multicenter study. Abstract 1970, Ciruclation (Supp) October 1996 ; 94 (8) (oral presentation). MORTENSEN P., KIRSTEIN-PEDERSEN A., HUVELLE E. Pectoral implantation of the new VENTAK MINI AICD Pulse generator. Abstract 1158, Eur. J.C.P.E. June 1996 ; + (I, Supp5) (Poster session). AURICCHIO A., KLEIN H., HUVELLE E., VOSHAGE STAHN L. Initial experience with the new VENTAK MINI HC/ENDOTAK DSP triad implantable cardioverter defibrillator system. Abstract 1080, EUR.J.C.P.E. June 1996 ; 6 (1, Supp5) (oral presentation). BRUGADA P., HUVELLE E. Initial experience with the nex VENTAK MINI AICD pulse generator. Abstract 1157, EUR.J.C.P.E. June 1996 ; 6 (1, Supp5) (Poster session). AURICCHIO A., KLEIN H., HUVELLE E., VOSHAGE STAHN L. Initial experience with the new VENTAK MINI HC/ENDOTAK DSP triad implantable cardioverter defibrillator system. Abstract 5, PACE, April 1996 ; 19 (4,Part II) (oral presentation). WILLEMS R., FERNANDEZ E., HUVELLE E., MITCHELL M. Clinical application of an endocardial lead system in ICD implantations. Abstract 242, PACE May 1993 ; 16 (5, Part II) (oral presentation). Communication orale Invité à Cardiostim 2004, samedi 19 juin : session 256 (future indications for CRT : which patients might benefit?), 2ème présentation (Patients with LBBB, Normal EF, with ventricular dyssynchrony?) Communication poster Heart failure 2099, lundi 1er juin : session clinical poster III (Acute heart failure), Poster 749 (left bundle branch block and mortality in patients with acute heart failure syndrome : a substudy of the EFICA cohort). Brevets US Patent #7,041,061 : KRAMER A., HUVELLE E. Quantification of cardiac wall motion asynchrony. May, 9, 2006.

US Patent #6,522,914 : HUVELLE E., CUESTA P. Method and appartuses for monitoring hemdynamic activities using an intracardiac impedance-derived parameter. Feb 18, 2003 Conférences